These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 8936585

  • 21. AGN 191976: a novel thromboxane A2-mimetic with ocular hypotensive properties.
    Krauss AH, Woodward DF, Chen J, Gibson LL, Lai RK, Protzman CE, Shan T, Williams LS, Gac TS, Burk RM.
    J Ocul Pharmacol Ther; 1995; 11(3):203-12. PubMed ID: 8590251
    [Abstract] [Full Text] [Related]

  • 22. Thromboxane A2 induces cell signaling but requires platelet-derived growth factor to act as a mitogen.
    Grosser T, Zucker TP, Weber AA, Schulte K, Sachinidis A, Vetter H, Schrör K.
    Eur J Pharmacol; 1997 Jan 29; 319(2-3):327-32. PubMed ID: 9042608
    [Abstract] [Full Text] [Related]

  • 23. Glomerular thromboxane A2/prostaglandin H2 receptors: characterization and effect of adriamycin-induced nephrotic syndrome.
    Mayeux PR, Shah SV.
    Biochim Biophys Acta; 1993 Apr 30; 1181(2):148-54. PubMed ID: 8481403
    [Abstract] [Full Text] [Related]

  • 24. The bovine thromboxane A2 receptor: molecular cloning, expression, and functional characterization.
    Muck S, Weber AA, Meyer-Kirchrath J, Schrör K.
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Jan 30; 357(1):10-6. PubMed ID: 9459567
    [Abstract] [Full Text] [Related]

  • 25. Thromboxane A2 receptor blockade suppresses intercellular adhesion molecule-1 expression by stimulated vascular endothelial cells.
    Ishizuka T, Suzuki K, Kawakami M, Hidaka T, Matsuki Y, Nakamura H.
    Eur J Pharmacol; 1996 Oct 03; 312(3):367-77. PubMed ID: 8894620
    [Abstract] [Full Text] [Related]

  • 26. Thromboxane-insensitive dog platelets have impaired activation of phospholipase C due to receptor-linked G protein dysfunction.
    Johnson GJ, Leis LA, Dunlop PC.
    J Clin Invest; 1993 Nov 03; 92(5):2469-79. PubMed ID: 8227362
    [Abstract] [Full Text] [Related]

  • 27. Homologous desensitization of human platelet thromboxane A2/prostaglandin H2 receptors.
    Okwu AK, Ullian ME, Halushka PV.
    J Pharmacol Exp Ther; 1992 Jul 03; 262(1):238-45. PubMed ID: 1378092
    [Abstract] [Full Text] [Related]

  • 28. Agonist-induced phosphorylation of human platelet TXA2/PGH2 receptors.
    Okwu AK, Mais DE, Halushka PV.
    Biochim Biophys Acta; 1994 Mar 10; 1221(1):83-8. PubMed ID: 8130280
    [Abstract] [Full Text] [Related]

  • 29. Glibenclamide inhibits thromboxane-mediated vasoconstriction by thromboxane receptor blockade.
    Pfister SL, Pratt PE, Kurian J, Campbell WB.
    Vascul Pharmacol; 2004 Jan 10; 40(6):285-92. PubMed ID: 15063832
    [Abstract] [Full Text] [Related]

  • 30. Reduced thromboxane receptor affinity and vasoconstrictor responses in placentae from diabetic pregnancies.
    Wilkes BM, Mento PF, Hollander AM.
    Placenta; 1994 Dec 10; 15(8):845-55. PubMed ID: 7886025
    [Abstract] [Full Text] [Related]

  • 31. Antagonism of thromboxane actions in the isolated perfused rat heart.
    Stahl GL, Darius H, Lefer AM.
    Life Sci; 1986 Jun 02; 38(22):2037-41. PubMed ID: 2940431
    [Abstract] [Full Text] [Related]

  • 32. Evidence for the distinct nature of F2-isoprostane receptors from those of thromboxane A2.
    Fukunaga M, Yura T, Grygorczyk R, Badr KF.
    Am J Physiol; 1997 Apr 02; 272(4 Pt 2):F477-83. PubMed ID: 9140048
    [Abstract] [Full Text] [Related]

  • 33. Mechanism for homologous downregulation of thromboxane A2 receptors in cultured human chronic myelogenous leukemia (K562) cells.
    Dorn GW.
    J Pharmacol Exp Ther; 1991 Oct 02; 259(1):228-34. PubMed ID: 1833525
    [Abstract] [Full Text] [Related]

  • 34. Effects of KW-3635, a novel dibenzoxepin derivative of a selective thromboxane A2 antagonist, on human, guinea pig and rat platelets.
    Miki I, Kishibayashi N, Nonaka H, Ohshima E, Takami H, Obase H, Ishii A.
    Jpn J Pharmacol; 1992 Jul 02; 59(3):357-64. PubMed ID: 1434130
    [Abstract] [Full Text] [Related]

  • 35. Antagonistic actions of S-145 on vascular and platelet thromboxane A2 receptors.
    Mihara S, Hara S, Ueda M, Ide M, Fujimoto M.
    Eur J Pharmacol; 1989 Nov 21; 171(2-3):179-87. PubMed ID: 2533558
    [Abstract] [Full Text] [Related]

  • 36. A comparative study of thromboxane (TP) receptor mimetics and antagonists on isolated human umbilical artery and myometrium.
    Abbas F, Amin Z, Burk RM, Krauss AH, Marshall K, Senior J, Woodward DF.
    Adv Exp Med Biol; 1997 Nov 21; 407():219-30. PubMed ID: 9321956
    [No Abstract] [Full Text] [Related]

  • 37. Characterization of the thromboxane receptor mediating prostacyclin release from cultured endothelial cells.
    Hunt JA, Merritt JE, MacDermot J, Keen M.
    Biochem Pharmacol; 1992 Apr 15; 43(8):1747-52. PubMed ID: 1315543
    [Abstract] [Full Text] [Related]

  • 38. Thromboxane A2-mediated shape change: independent of Gq-phospholipase C--Ca2+ pathway in rabbit platelets.
    Ohkubo S, Nakahata N, Ohizumi Y.
    Br J Pharmacol; 1996 Mar 15; 117(6):1095-104. PubMed ID: 8882602
    [Abstract] [Full Text] [Related]

  • 39. Comparison of vascular and platelet thromboxane A2/prostaglandin H2 receptors in the pig.
    Mihara S, Hara S, Ueda M, Ide M, Fujimoto M.
    Eur J Pharmacol; 1989 Feb 07; 160(3):313-21. PubMed ID: 2523812
    [Abstract] [Full Text] [Related]

  • 40. Prostaglandin I2 mediates contraction and relaxation of vascular smooth muscle.
    Williams SP, Dorn GW, Rapoport RM.
    Am J Physiol; 1994 Aug 07; 267(2 Pt 2):H796-803. PubMed ID: 8067435
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.